Source comparison
How Much Does CJC-1295 Cost 2026: Standard vs DAC vs Modified Formulations Comparison
This table compares the three primary CJC-1295 formulations available in 2026 across cost, dosing requirements, and application suitability. CJC-1295 (No-DAC) $45–$60 60mg (twice daily, 1mg/dose) 30 minutes Acute GH pulse studies, pulsatile signaling research
This comparison does not assign a generated winner or score.
- This table compares the three primary CJC-1295 formulations available in 2026 across cost, dosing requirements, and application suitability.
- CJC-1295 (No-DAC)
- $45–$60
- 60mg (twice daily, 1mg/dose)
- 30 minutes
- Acute GH pulse studies, pulsatile signaling research
- Lowest per-vial cost but highest monthly expense due to frequent dosing. Suitable only for protocols requiring natural pulsatile patterns
- CJC-1295 with DAC
- $65–$85
- 16mg (twice weekly, 2mg/dose)
- 6–8 days
- Chronic GH elevation studies, sustained-release modeling
- Highest per-vial cost but lowest monthly expense. Extended half-life reduces dosing frequency by 75% and total peptide consumption by 73%
- Modified GRF (1-29)
- $50–$70
- 30mg (daily, 1mg/dose)
- 30 minutes (identical to no-DAC)
- GH secretagogue stacking protocols, combination studies with GHRP-2 or GHRP-6
- Mid-range pricing with moderate dosing frequency. Preferred when studying synergistic effects with ghrelin mimetics due to complementary receptor pathways